131 results on '"Nakata, Kensei"'
Search Results
2. Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy
3. A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015)
4. Influence of PD-L1 expression in immune cells on the response to radiation therapy in patients with oropharyngeal squamous cell carcinoma
5. Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer
6. Dose Prescription and Calculation
7. Relation between Ku80 and microRNA-99a expression and late rectal bleeding after radiotherapy for prostate cancer
8. Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy
9. Expression of Ku70 predicts results of radiotherapy in prostate cancer
10. Prediction of acute gastrointestinal and genitourinary radiation toxicity in prostate cancer patients using lymphocyte microRNA
11. Influence of Ku86 and XRCC4 expression in uterine cervical cancer on the response to preoperative radiotherapy
12. Additional file 1 of Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)
13. The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy
14. Dose verifications by use of liquid ionization chamber of an electronic portal imaging device (EPID)
15. Hyperfractionated Accelerated Radiotherapy for T1,2 Glottic Carcinoma: Consideration of Time-Dose Factors
16. Analysis of Local Control in Patients with Non-Hodgkin’s Lymphoma According to the WHO Classification
17. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer
18. Brachytherapy for Oral Tongue Cancer: An Analysis of Treatment Results with Various Biological Markers
19. The Changes in Irradiated Salivary Gland Function of Patients with Head and Neck Tumors Treated with Radiotherapy
20. Long-term results of a PII study of chemoradiotherapy with docetaxel, nedaplatin, and fluorouracil for esophageal cancer
21. Efficacy of combined radiotherapy and anti‐programmed death 1 therapy in acral and mucosal melanoma
22. Four－fraction radiation therapy for non－melanoma skin cancer
23. Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study
24. Prediction of acute gastrointestinal and genitourinary radiation toxicity in prostate cancer patients using lymphocyte microRNA
25. Method for Converting Cone-Beam CT Values into Hounsfield Units for Radiation Treatment Planning
26. MO1-17-2 - Long-term results of a PII study of chemoradiotherapy with docetaxel, nedaplatin, and fluorouracil for esophageal cancer
27. Local tumor control and DNA-PK activity of peripheral blood lymphocytes in prostate cancer patients receiving radiotherapy
28. Expression of Ku70 predicts results of radiotherapy in prostate cancer
29. Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy
30. A Phase 1/2 Study of Definitive Chemoradiation Therapy Using Docetaxel, Nedaplatin, and 5-Fluorouracil (DNF-R) for Esophageal Cancer
31. Analysis of Prostate Deformation during a Course of Radiation Therapy for Prostate Cancer
32. Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study
33. Ku70-Expression prognostiziert Ergebnisse der Strahlentherapie beim Prostatakarzinom.
34. Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer
35. Effects of Beam Startup Characteristics on Dose Delivery Accuracy at Low Monitor Units in Step-and-Shoot Intensity Modulated Radiation Therapy
36. Analysis and results of Ku and XRCC4 expression in hypopharyngeal cancer tissues treated with chemoradiotherapy
37. A clinical survey of hospitalization with radical radiotherapy for early stage glottic laryngeal cancer
38. Local tumor control and DNA-PK activity of peripheral blood lymphocytes in prostate cancer patients receiving radiotherapy.
39. The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy
40. The application of theory of altered fractionation on clinics
41. A Clinical Study of Hypoxia Using Endogenous Hypoxic Markers and Polarographic Oxygen Electrodes
42. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy
43. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non‐Hodgkin lymphoma
44. High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications
45. ANALYSIS OF HYPOPHARYNGEAL CARCINOMA-STRATEGIES OF TREATMENT FOR N2 PIRIFORM SINUS CARCINOMA
46. Pancreas: imaging diagnosis with color/power Doppler ultrasonography, endoscopic ultrasonography, and intraductal ultrasonography
47. Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer
48. Multi-Institutional Analysis of Solitary Extramedullary Plasmacytoma of the Head and Neck Treated With Curative Radiotherapy
49. [Clinical Efficacy of Cepharanthin(R)for Radiotherapy-Induced Leukopenia - A Nationwide, Multicenter, and Observational Study].
50. [Clinical application of altered fractionation theory].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.